History
-
2024
- 09Held a completion ceremony for the expansion of the automated warehouse at the Anseong Plant
- 08Acquired Bifido Co., Ltd., a global company specializing in bifidobacteria
- 02Held a completion ceremony for the expansion of the finished goods warehouse at the Hyangnam Plant
- 02Obtained PMDA approval in Japan for Escitalopram Tablets
- 02Acquisition of Japanese GMP Certification
- 01Signed an exclusive domestic sales and distribution agreement for Sanofi Arava Tablets
-
2023
- 12Achieving Million Dollar Export Performance
- 12Promotion & Distribution Agreement with Sanofi-Aventis Korea(ARAVA® )
-
02Acquisition of GMP certification for Hyangnam Plant
-
01Central Research and Development Laboratory relocated to newly completed facilities in yongin city
-
2022
-
11Acquisition of EAEU GMP Certification
-
11Co-promotion & Distribution Agreement with GSK(REQUIP, REQUIP PD, IMIGRAN, NARAMIG, PAXIL CR, WELLBUTRIN XL, SEROXAT)
-
04Received approval as the first individually recognized functional material related to persimmon leaf alcohol extract and xerophthalmia
-
-
2021
- 12Acquired certification of Quality Management System ‘ISO 9001’
-
2020
- 11Signed a contract to take Hyangnam Plant in Janssen, Korea
- 03Subsidiary Company, AsYou Co., Ltd. was founded
- 03License & Distribution Agreement with Gedeon Richter (REAGILA)
- 02Joint Agreement with Ybrain for a wireless EEG system MINDD SCAN